A globally-renowned prostate cancer surgeon shares the latest advancements in the field and stresses the importance of early ...

An international study reports that the combination of two drugs could significantly retard the development of a dangerous form of prostate cancer in men who have specific mutations in DNA repair ...

A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, ...

A targeted drug combination delays advanced prostate cancer in men with specific DNA repair gene mutations. A large international study led by researchers at UCL has found that a new combination of dr ...

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, and University College London (UCL) today announced that data published online in Cell show that the Decipher Prostate Genomic ...

The “striking” findings showed an overall upward trend in life expectancy when patients took niraparib - a targeted therapy ...

The Galleri test aims to find fragments of DNA in a person’s blood that can indicate the presence of a cancerous tumor.

A powerful new drug combination—niraparib added to standard prostate cancer therapy—has been shown to significantly delay ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

The media frenzy surrounding former President Joe Biden’s metastatic prostate cancer diagnosis last May didn’t faze one Lancaster resident. Doctors and politicians debated whether Biden and his ...

With the backing of Rishi Sunak, Prostate Cancer UK published a report to the national screening committee back in 2022 in ...